Mankind Pharma to integrate Bharat Serums & Vaccines via voluntary liquidation

Mankind Pharma Limited's Board of Directors has approved the integration of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited (BSVL), through a voluntary liquidation process. BSVL's business will be consolidated into Mankind Pharma on a going concern basis, subject to regulatory approvals. Appian Properties Private Limited, a 4% shareholder in BSVL, will receive cash proportionate to its stake based on an independent valuation. This move aims to drive operational efficiency, improve organizational execution, enhance cash management, reduce compliance, and rationalize expenses by consolidating operations into a single entity. The voluntary liquidation will be managed by a liquidator appointed by BSVL, adhering to the Insolvency and Bankruptcy Code, 2016.